A detailed history of Compagnie Lombard Odier S Cm A transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Compagnie Lombard Odier S Cm A holds 31 shares of GILD stock, worth $2,786. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31
Previous 1,250 97.52%
Holding current value
$2,786
Previous $85,000 97.65%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$66.59 - $83.99 $81,173 - $102,383
-1,219 Reduced 97.52%
31 $2,000
Q1 2024

May 01, 2024

SELL
$71.58 - $87.29 $3.25 Million - $3.96 Million
-45,410 Reduced 97.32%
1,250 $91,000
Q4 2023

Jan 16, 2024

BUY
$73.27 - $83.09 $3.14 Million - $3.56 Million
42,851 Added 1124.99%
46,660 $3.78 Million
Q3 2023

Oct 23, 2023

SELL
$73.94 - $80.67 $2.18 Million - $2.38 Million
-29,477 Reduced 88.56%
3,809 $285,000
Q2 2023

Aug 07, 2023

SELL
$76.01 - $86.7 $129,825 - $148,083
-1,708 Reduced 4.88%
33,286 $2.57 Million
Q1 2023

May 01, 2023

SELL
$77.31 - $88.08 $92,926 - $105,872
-1,202 Reduced 3.32%
34,994 $2.9 Million
Q4 2022

Feb 13, 2023

BUY
$62.32 - $89.47 $189,889 - $272,615
3,047 Added 9.19%
36,196 $3.11 Million
Q3 2022

Nov 09, 2022

SELL
$59.54 - $68.01 $30,067 - $34,345
-505 Reduced 1.5%
33,149 $2.04 Million
Q2 2022

Aug 11, 2022

SELL
$57.72 - $65.01 $48,080 - $54,153
-833 Reduced 2.42%
33,654 $2.08 Million
Q1 2022

Apr 27, 2022

SELL
$57.92 - $72.58 $175,960 - $220,498
-3,038 Reduced 8.1%
34,487 $2.05 Million
Q4 2021

Feb 09, 2022

SELL
$64.88 - $73.64 $61,635 - $69,958
-950 Reduced 2.47%
37,525 $2.72 Million
Q3 2021

Oct 28, 2021

SELL
$67.69 - $73.03 $162,456 - $175,272
-2,400 Reduced 5.87%
38,475 $2.69 Million
Q2 2021

Jul 15, 2021

BUY
$63.47 - $69.35 $137,476 - $150,212
2,166 Added 5.6%
40,875 $2.82 Million
Q1 2021

Apr 23, 2021

BUY
$60.0 - $68.46 $99,180 - $113,164
1,653 Added 4.46%
38,709 $2.5 Million
Q4 2020

Feb 09, 2021

BUY
$56.65 - $64.55 $19,600 - $22,334
346 Added 0.94%
37,056 $2.16 Million
Q3 2020

Nov 12, 2020

SELL
$62.1 - $78.08 $232,875 - $292,800
-3,750 Reduced 9.27%
36,710 $2.32 Million
Q2 2020

Aug 14, 2020

BUY
$72.34 - $84.0 $33,276 - $38,640
460 Added 1.15%
40,460 $3.11 Million
Q1 2020

May 13, 2020

SELL
$62.63 - $80.22 $573,690 - $734,815
-9,160 Reduced 18.63%
40,000 $2.99 Million
Q4 2019

Feb 13, 2020

BUY
$61.62 - $67.78 $1.48 Million - $1.63 Million
23,981 Added 95.24%
49,160 $3.19 Million
Q3 2019

Nov 12, 2019

BUY
$62.51 - $69.0 $37,506 - $41,400
600 Added 2.44%
25,179 $1.6 Million
Q2 2019

Aug 14, 2019

SELL
$61.87 - $69.38 $253,357 - $284,111
-4,095 Reduced 14.28%
24,579 $1.66 Million
Q1 2019

May 13, 2019

SELL
$62.53 - $70.05 $4.95 Million - $5.55 Million
-79,200 Reduced 73.42%
28,674 $1.87 Million
Q4 2018

Feb 13, 2019

BUY
$60.54 - $79.0 $25,063 - $32,706
414 Added 0.39%
107,874 $6.75 Million
Q3 2018

Nov 13, 2018

BUY
$71.28 - $78.92 $219,827 - $243,389
3,084 Added 2.95%
107,460 $8.3 Million
Q2 2018

Aug 10, 2018

SELL
$64.88 - $75.68 $279,827 - $326,407
-4,313 Reduced 3.97%
104,376 $7.4 Million
Q1 2018

May 11, 2018

SELL
$72.84 - $88.8 $1.49 Million - $1.82 Million
-20,519 Reduced 15.88%
108,689 $8.19 Million
Q4 2017

Feb 13, 2018

SELL
$71.15 - $83.52 $3.22 Million - $3.78 Million
-45,251 Reduced 25.94%
129,208 $9.26 Million
Q3 2017

Nov 14, 2017

SELL
$72.11 - $85.47 $2.84 Million - $3.37 Million
-39,448 Reduced 18.44%
174,459 $14.1 Million
Q2 2017

Aug 14, 2017

BUY
N/A
213,907
213,907 $15.1 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Compagnie Lombard Odier S Cm A Portfolio

Follow Compagnie Lombard Odier S Cm A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

News

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.